| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Antimicrobial Susceptibility, Nocardia/Aerobic Actinomycetes, MIC
Test Code90396
CPT Codes
87186
Includes
Amikacin, Amoxicillin/Clavulanate, Ceftriaxone, Ciprofloxacin, Clarithromycin, Doxycycline, Imipenem, Linezolid, Minocycline, Moxifloxacin, Tobramycin, Trimethoprim/Sulfamethoxazole
Preferred Specimen
Pure culture of Nocardia spp., or other aerobic actinomycetes safely contained (including but not limited to: Rhodococcus, Gordonia, Tsukamurella, Streptomyces)
Instructions
Identification of the isolate is required
Transport Temperature
Room temperature
Specimen Stability
Room temperature: Determined by viability
Refrigerated: Determined by viability
Frozen: Unacceptable
Refrigerated: Determined by viability
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Mixed cultures or organisms not considered nocardia or aerobic actinomycetes • Raw specimens • Frozen isolates • Isolates overgrown with bacteria, yeast, fungi
Methodology
Broth Microdilution
FDA Status
This test was performed using a kit that has not been cleared or approved by the FDA. The analytical performance characteristics of this test have been determined by Quest Diagnostics. This test should not be used for diagnosis without confirmation by other medically established means.
Setup Schedule
Set up: Mon, Tue, Fri; Report available: 18-19 days
Clinical Significance
Rapidly growing mycobacteria and Nocardia/aerobic actinomycetes can cause a variety of serious infections, particularly in immunocompromised patients. Resistance, toxicity, intolerance, and therapeutic failures may occur with traditional empiric treatment with drugs of choice. Antimicrobial susceptibility testing, especially with newer agents, may help to guide appropriate therapeutic choices.
